|
|
Volumn 5, Issue 5, 1996, Pages 581-593
|
|
Pharmacology of antimigraine 5-HT(1D) receptor agonists
|
|
Author keywords
Alniditan; Antimigraine drugs; Arteriovenous anastomoses; BMS 180048; Migraine; MK 462; Naratriptan; Sumatriptan; Zolmitriptan
|
|
Indexed keywords
5 CARBAMOYLTRYPTAMINE;
ADENYLATE CYCLASE;
AH 25086;
ALNIDITAN;
ANTIMIGRAINE AGENT;
AVITRIPTAN;
METERGOLINE;
METITEPINE;
N [4 METHOXY 3 (4 METHYL 1 PIPERAZINYL)PHENYL] 2' METHYL 4' (5 METHYL 1,2,4 OXADIAZOL 3 YL)[1,1' BIPHENYL] 4 CARBOXAMIDE;
NARATRIPTAN;
RECEPTOR SUBTYPE;
RIZATRIPTAN;
SEROTONIN 1D AGONIST;
SEROTONIN 1D ALPHA RECEPTOR;
SEROTONIN 1D BETA RECEPTOR;
SEROTONIN 1D RECEPTOR;
SUMATRIPTAN;
UNCLASSIFIED DRUG;
ZOLMITRIPTAN;
ANIMAL MODEL;
ARTERIOVENOUS FISTULA;
CARDIOVASCULAR SYSTEM;
CLINICAL TRIAL;
CLUSTER HEADACHE;
CORONARY ARTERY DISEASE;
DRUG BIOAVAILABILITY;
DRUG CONTRAINDICATION;
DRUG DESIGN;
DRUG SELECTIVITY;
HUMAN;
MIGRAINE;
NERVOUS SYSTEM;
NONHUMAN;
RECURRENT DISEASE;
REVIEW;
|
|
EID: 0029943941
PISSN: 13543784
EISSN: None
Source Type: Journal
DOI: 10.1517/13543784.5.5.581 Document Type: Review |
|
Times cited : (19)
|
|
References (0)
|
